Published in Women's Health Weekly, July 10th, 2008
On Tuesday, June 17, at 3:15 p.m. PDT, Baxter Phillips, III, Senior Director of Corporate Development at Osteologix, will present a corporate overview on the NB S101 development program during the BIO International Convention Business Forum.
On Wednesday, June 18, the Company will present the poster entitled, "Effect of Three Doses of Strontium Malonate (NB S101)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.